miRNA | gene name | experiments | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
hsa-miR-143-3p | KRAS |
|
||||||||||||||
hsa-miR-143-3p | MYO6 |
|
||||||||||||||
hsa-miR-143-3p | DNMT3A |
|
||||||||||||||
hsa-miR-143-3p | FNDC3B |
|
||||||||||||||
hsa-miR-143-3p | COX2 |
|
||||||||||||||
hsa-miR-143-3p | HRAS |
|
||||||||||||||
hsa-miR-143-3p | HK2 |
|
||||||||||||||
hsa-miR-143-3p | SERPINE1 |
|
||||||||||||||
hsa-miR-143-3p | FHIT |
|
||||||||||||||
hsa-miR-143-3p | MACC1 |
|
||||||||||||||
hsa-miR-143-3p | PTGS2 |
|
||||||||||||||
hsa-miR-143-3p | AKT1 |
|
||||||||||||||
hsa-miR-143-3p | MDM2 |
|
||||||||||||||
hsa-miR-143-3p | BCL2 |
|
||||||||||||||
hsa-miR-143-3p | MMP13 |
|
||||||||||||||
hsa-miR-143-3p | SDC1 |
|
||||||||||||||
hsa-miR-143-3p | RREB1 |
|
||||||||||||||
hsa-miR-143-3p | CD44 |
|
||||||||||||||
hsa-miR-143-3p | KLF5 |
|
||||||||||||||
hsa-miR-143-3p | BRAF |
|
||||||||||||||
hsa-miR-143-3p | MAP3K7 |
|
||||||||||||||
hsa-miR-143-3p | CHST10 |
|
||||||||||||||
hsa-miR-143-3p | MAPK1 |
|
||||||||||||||
hsa-miR-143-3p | COL5A1 |
|
||||||||||||||
hsa-miR-143-3p | PDGFRA |
|
||||||||||||||
hsa-miR-143-3p | SMAD3 |
|
||||||||||||||
hsa-miR-143-3p | CTNND1 |
|
||||||||||||||
hsa-miR-143-3p | COL5A2 |
|
||||||||||||||
hsa-miR-143-3p | ERBB3 |
|
||||||||||||||
hsa-miR-143-3p | IGF1R |
|
||||||||||||||
hsa-miR-143-3p | RAB22A |
|
||||||||||||||
hsa-miR-143-3p | RBM27 |
|
||||||||||||||
hsa-miR-143-3p | USP42 |
|
||||||||||||||
hsa-miR-143-3p | CMPK1 |
|
||||||||||||||
hsa-miR-143-3p | SAMD8 |
|
||||||||||||||
hsa-miR-143-3p | BTF3L4 |
|
||||||||||||||
hsa-miR-143-3p | KAT7 |
|
||||||||||||||
hsa-miR-143-3p | ZNF264 |
|
||||||||||||||
hsa-miR-143-3p | CALM3 |
|
||||||||||||||
hsa-miR-143-3p | PRRC2B |
|
||||||||||||||
hsa-miR-143-3p | ORAI2 |
|
||||||||||||||
hsa-miR-143-3p | TNF |
|
||||||||||||||
hsa-miR-143-3p | NR2C2 |
|
||||||||||||||
hsa-miR-143-3p | IL13RA1 |
|
||||||||||||||
hsa-miR-143-3p | COL3A1 |
|
||||||||||||||
hsa-miR-143-3p | DDX6 |
|
||||||||||||||
hsa-miR-143-3p | LIMK1 |
|
||||||||||||||
hsa-miR-143-3p | HNF4A |
|
||||||||||||||
hsa-miR-143-3p | CASP5 |
|
||||||||||||||
hsa-miR-143-3p | LRIT3 |
|
||||||||||||||
hsa-miR-143-3p | NAPEPLD |
|
||||||||||||||
hsa-miR-143-3p | PAPPA |
|
||||||||||||||
hsa-miR-143-3p | VOPP1 |
|
||||||||||||||
hsa-miR-143-3p | FAM120AOS |
|
||||||||||||||
hsa-miR-143-3p | C1orf61 |
|
||||||||||||||
hsa-miR-143-3p | PGLS |
|
||||||||||||||
hsa-miR-143-3p | YARS |
|
||||||||||||||
hsa-miR-143-3p | HAAO |
|
||||||||||||||
hsa-miR-143-3p | SYT7 |
|
||||||||||||||
hsa-miR-143-3p | ZC3HAV1L |
|
||||||||||||||
hsa-miR-143-3p | UCK2 |
|
||||||||||||||
hsa-miR-143-3p | TAF1D |
|
||||||||||||||
hsa-miR-143-3p | SLC2A14 |
|
||||||||||||||
hsa-miR-143-3p | SLC25A25 |
|
||||||||||||||
hsa-miR-143-3p | SGPL1 |
|
||||||||||||||
hsa-miR-143-3p | SECISBP2L |
|
||||||||||||||
hsa-miR-143-3p | RER1 |
|
||||||||||||||
hsa-miR-143-3p | PPP2R5E |
|
||||||||||||||
hsa-miR-143-3p | NFIC |
|
||||||||||||||
hsa-miR-143-3p | NCKAP1 |
|
||||||||||||||
hsa-miR-143-3p | KLK10 |
|
||||||||||||||
hsa-miR-143-3p | GXYLT1 |
|
||||||||||||||
hsa-miR-143-3p | CSRNP2 |
|
||||||||||||||
hsa-miR-143-3p | BBC3 |
|
||||||||||||||
hsa-miR-143-3p | TFPI |
|
||||||||||||||
hsa-miR-143-3p | GLRA3 |
|
||||||||||||||
hsa-miR-143-3p | PLEKHM3 |
|
||||||||||||||
hsa-miR-143-3p | ZNF607 |
|
||||||||||||||
hsa-miR-143-3p | TUBB2A |
|
||||||||||||||
hsa-miR-143-3p | ENO4 |
|
||||||||||||||
hsa-miR-143-3p | DBT |
|
||||||||||||||
hsa-miR-143-3p | ADAMTS4 |
|
||||||||||||||
hsa-miR-143-3p | OR7D2 |
|
||||||||||||||
hsa-miR-143-3p | SPTLC2 |
|
||||||||||||||
hsa-miR-143-3p | XIAP |
|
||||||||||||||
hsa-miR-143-3p | PHAX |
|
||||||||||||||
hsa-miR-143-3p | RPS27 |
|
||||||||||||||
hsa-miR-143-3p | YWHAB |
|
||||||||||||||
hsa-miR-143-3p | GGA2 |
|
||||||||||||||
hsa-miR-143-3p | ZBTB44 |
|
||||||||||||||
hsa-miR-143-3p | STOX2 |
|
||||||||||||||
hsa-miR-143-3p | NFYB |
|
||||||||||||||
hsa-miR-143-3p | IGFBP5 |
|
||||||||||||||
hsa-miR-143-3p | IER5 |
|
||||||||||||||
hsa-miR-143-3p | COMMD2 |
|
||||||||||||||
hsa-miR-143-3p | CENPP |
|
||||||||||||||
hsa-miR-143-3p | ZNF277 |
|
||||||||||||||
hsa-miR-143-3p | SLC30A9 |
|
||||||||||||||
hsa-miR-143-3p | NUDT3 |
|
||||||||||||||
hsa-miR-143-3p | OAS3 |
|
||||||||||||||
hsa-miR-143-3p | GALNT6 |
|
||||||||||||||
hsa-miR-143-3p | TTC38 |
|
||||||||||||||
hsa-miR-143-3p | LRAT |
|
||||||||||||||
hsa-miR-143-3p | ADH5 |
|
||||||||||||||
hsa-miR-143-3p | SLC25A33 |
|
||||||||||||||
hsa-miR-143-3p | FAXC |
|
||||||||||||||
hsa-miR-143-3p | NUBPL |
|
||||||||||||||
hsa-miR-143-3p | SCN2B |
|
||||||||||||||
hsa-miR-143-3p | CERS4 |
|
||||||||||||||
hsa-miR-143-3p | HYPK |
|
||||||||||||||
hsa-miR-143-3p | TRIM71 |
|
||||||||||||||
hsa-miR-143-3p | TIMM8A |
|
||||||||||||||
hsa-miR-143-3p | CREG2 |
|
||||||||||||||
hsa-miR-143-3p | C2orf15 |
|
||||||||||||||
hsa-miR-143-3p | SKAP2 |
|
||||||||||||||
hsa-miR-143-3p | ELP2 |
|
||||||||||||||
hsa-miR-143-3p | ZNF573 |
|
||||||||||||||
hsa-miR-143-3p | ANKRD9 |
|
||||||||||||||
hsa-miR-143-3p | FAM71F2 |
|
||||||||||||||
hsa-miR-143-3p | ZNF429 |
|
||||||||||||||
hsa-miR-143-3p | IKZF3 |
|
||||||||||||||
hsa-miR-143-3p | KIAA0930 |
|
||||||||||||||
hsa-miR-143-3p | SLC25A16 |
|
||||||||||||||
hsa-miR-143-3p | GTF2H5 |
|
||||||||||||||
hsa-miR-143-3p | UBE2V2 |
|
||||||||||||||
hsa-miR-143-3p | LRRC2 |
|
||||||||||||||
hsa-miR-143-3p | C1orf50 |
|
||||||||||||||
hsa-miR-143-3p | RUNDC1 |
|
||||||||||||||
hsa-miR-143-3p | THAP1 |
|
||||||||||||||
hsa-miR-143-3p | SLC35F6 |
|
||||||||||||||
hsa-miR-143-3p | ZNF440 |
|
||||||||||||||
hsa-miR-143-3p | DCTN6 |
|
||||||||||||||
hsa-miR-143-3p | PLEKHA1 |
|
||||||||||||||
hsa-miR-143-3p | MYCBP |
|
||||||||||||||
hsa-miR-143-3p | PRR23A |
|
||||||||||||||
hsa-miR-143-3p | NPR1 |
|
||||||||||||||
hsa-miR-143-3p | FGD6 |
|
||||||||||||||
hsa-miR-143-3p | CCR6 |
|
||||||||||||||
hsa-miR-143-3p | FSD2 |
|
||||||||||||||
hsa-miR-143-3p | IL10RB |
|
||||||||||||||
hsa-miR-143-3p | MYPN |
|
||||||||||||||
hsa-miR-143-3p | RPS19 |
|
||||||||||||||
hsa-miR-143-3p | PPIL4 |
|
||||||||||||||
hsa-miR-143-3p | SFT2D2 |
|
||||||||||||||
hsa-miR-143-3p | RAB33B |
|
||||||||||||||
hsa-miR-143-3p | MIER3 |
|
||||||||||||||
hsa-miR-143-3p | ACOT9 |
|
||||||||||||||
hsa-miR-143-3p | GJD2 |
|
||||||||||||||
hsa-miR-143-3p | RRP7A |
|
||||||||||||||
hsa-miR-143-3p | GLUL |
|
||||||||||||||
hsa-miR-143-3p | PNPO |
|
||||||||||||||
hsa-miR-143-3p | ABAT |
|
authors | journal | year | Pubmed link | title | |
---|---|---|---|---|---|
1 | Pagliuca et al. | Oncogene | 2013 | 23128394 | Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. |
2 | Chen et al. | Oncogene | 2009 | 19137007 | Role of miR-143 targeting KRAS in colorectal tumorigenesis. |
3 | Lin et al. | J. Urol. | 2009 | 19157460 | MicroRNA-143 as a tumor suppressor for bladder cancer. |
4 | Ni et al. | Gene | 2013 | 23276710 | MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. |
5 | Szczyrba et al. | Mol. Cancer Res. | 2010 | 20353999 | The microRNA profile of prostate carcinoma obtained by deep sequencing. |
6 | Borralho et al. | FEBS J. | 2009 | 19843160 | MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. |
7 | Ng et al. | Br. J. Cancer | 2009 | 19638978 | MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. |
8 | Ng et al. | Tumour Biol. | 2014 | 24218337 | MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells. |
9 | Zhang et al. | Hepatology | 2009 | 19472311 | Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. |
10 | Iorio et al. | Cancer Res. | 2007 | 17875710 | MicroRNA signatures in human ovarian cancer. |
11 | Gao et al. | FEBS Lett. | 2011 | 21276449 | The Evi1, microRNA-143, K-Ras axis in colon cancer. |
12 | Yoshino et al. | Cancer Sci. | 2013 | 24033605 | Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma. |
13 | Jiang et al. | EMBO J. | 2012 | 22354042 | A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. |
14 | Fang et al. | J. Biol. Chem. | 2012 | 22593586 | MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. |
15 | Gregersen et al. | BMC Cancer | 2012 | 22691140 | MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells. |
16 | Zhao et al. | Cancer Lett. | 2013 | 23376635 | miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. |
17 | Villadsen et al. | Br. J. Cancer | 2012 | 22108519 | The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. |
18 | Lin et al. | Cancer Biother. Radiopharm. | 2011 | 21711110 | microRNA-143 protects cells from DNA damage-induced killing by downregulating FHIT expression. |
19 | Zhang et al. | Mol. Cancer | 2012 | 22533346 | MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. |
20 | Zhao et al. | Stem Cells | 2014 | 24105952 | The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143. |
21 | Song et al. | Asian Pac. J. Cancer Prev. | 2011 | 21790228 | Expression of miR-143 reduces growth and migration of human bladder carcinoma cells by targeting cyclooxygenase-2. |
22 | Noguchi et al. | Cancer Lett. | 2013 | 23104321 | Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. |
23 | Zhang et al. | Oncogene | 2013 | 22330136 | Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. |
24 | Liu et al. | Mol Med Rep | 2012 | 22160209 | miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. |
25 | Zhuang et al. | Tumour Biol. | 2015 | 25492481 | Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2. |
26 | Osaki et al. | Mol. Ther. | 2011 | 21427707 | MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. |
27 | Wu et al. | Mol Med Rep | 2013 | 23732700 | MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer. |
28 | Li et al. | PLoS ONE | 2014 | 24722758 | MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma. |
29 | Kent et al. | Oncogene | 2013 | 22751122 | RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. |
30 | Bakhshandeh et al. | J. Genet. | 2012 | 22942087 | A microRNA signature associated with chondrogenic lineage commitment. |
31 | Memczak et al. | Nature | 2013 | 23446348 | Circular RNAs are a large class of animal RNAs with regulatory potency. |
32 | Kishore et al. | Nat. Methods | 2011 | 21572407 | A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. |
33 | Whisnant et al. | MBio | 2013 | 23592263 | In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. |
34 | Hafner et al. | Cell | 2010 | 20371350 | Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. |
35 | Kopp et al. | Gene Ther. | 2013 | 23804075 | De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells. |
36 | Yu et al. | Int J Mol Sci | 2013 | 23965966 | MicroRNA-143 downregulates interleukin-13 receptor alpha1 in human mast cells. |
37 | Naito et al. | Cancer Sci. | 2014 | 24283360 | MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. |
38 | Iio et al. | Biochim. Biophys. Acta | 2013 | 23932921 | DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells. |
39 | Xia et al. | Int J Mol Sci | 2014 | 25003638 | miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1. |
40 | Wang et al. | Biochim. Biophys. Acta | 2013 | 23298640 | The role of microRNAs in hepatocyte nuclear factor-4alpha expression and transactivation. |
41 | Gottwein et al. | Cell Host Microbe | 2011 | 22100165 | Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. |
42 | Kishore et al. | Genome Biol. | 2013 | 23706177 | Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing. |
43 | Farazi et al. | Genome Biol. | 2014 | 24398324 | Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. |
44 | Skalsky et al. | PLoS Pathog. | 2012 | 22291592 | The viral and cellular microRNA targetome in lymphoblastoid cell lines. |
45 | Karginov et al. | Genes Dev. | 2013 | 23824327 | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. |
46 | Lipchina et al. | Genes Dev. | 2011 | 22012620 | Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. |
47 | Xue et al. | Cell | 2013 | 23313552 | Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. |
48 | Haecker et al. | PLoS Pathog. | 2012 | 22927820 | Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. |
49 | Chi et al. | Nature | 2009 | 19536157 | Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. |